IKANOS: A Prospective, Open-Label, Minimally Interventional Hybrid Study in the US Comparing Initiation of Breztri Maintenance Versus Any Non-Triple Inhaled Therapy at Discharge After a Hospitalization for a COPD Exacerbation
Latest Information Update: 25 Apr 2024
At a glance
- Drugs Budesonide/formoterol/glycopyrrolate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms IKANOS
- Sponsors AstraZeneca
Most Recent Events
- 31 Jan 2024 Status changed from not yet recruiting to withdrawn prior to enrolment (due to recruitment challenges).
- 31 Dec 2023 Planned initiation date changed from 15 Jan 2024 to 19 Jan 2024.
- 14 Dec 2023 Planned End Date changed from 15 Dec 2025 to 31 Dec 2025.